Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News | ACC

December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors ...

Home December 22, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

December 17, 2015 — The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III ...

Home December 17, 2015
Home
News | EP Lab

December 8, 2015 — Biotronik announced the first patient enrollments to the B3 clinical trial. The study will evaluate ...

Home December 08, 2015
Home
News

November 24, 2015 — Biosense Webster announced it has acquired Coherex Medical Inc., a privately held medical device ...

Home November 24, 2015
Home
News | Left Atrial Appendage (LAA) Occluders

November 20, 2015 — Boston Scientific announced the first implants of the Watchman FLX left atrial appendage closure ...

Home November 20, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

November 11, 2015 — Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new ...

Home November 11, 2015
Home
News | Stroke

November 3, 2015 — In recognition of World Stroke Day, the patient-focused organization StopAfib.org launched a diverse ...

Home November 03, 2015
Home
News | Left Atrial Appendage (LAA) Occluders

October 28, 2015 — SentreHeart Inc. announced that it has received CE Mark approval for the Lariat Surgical Left Atrial ...

Home October 28, 2015
Home
Technology | Antiplatelet and Anticoagulation Therapies

October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab) ...

Home October 19, 2015
Home
News

October 14, 2015 — AtriCure Inc. announced it has entered into a definitive merger agreement under which AtriCure has ...

Home October 14, 2015
Home
News | EP Mapping and Imaging Systems

October 6, 2015 — Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High ...

Home October 06, 2015
Home
Technology

October 2, 2015 — AtriCure Inc. launched the cryoFORM cryoablation probe, which offers increased probe flexibility to ...

Home October 02, 2015
Home
News | Atrial Fibrillation

September 24, 2015 — The American College of Cardiology (ACC) launched two new clinical registry programs in August to ...

Home September 24, 2015
Home
MedLumics, OCT, real-time assessment, catheter ablation, atrial fibrillation
Feature | EP Mapping and Imaging Systems

September 17, 2015 — MedLumics has announced the completion of a successful single-case pre-clinical feasibility study ...

Home September 17, 2015
Home
Texas Heart Institute, Rice University, grant, nanotubes, heart, electrical signals
Feature | EP Lab

September 14, 2015 — Texas Heart Institute (THI) announced that it has received a prestigious American Heart Association ...

Home September 14, 2015
Home
Subscribe Now